ACN Newswire
Read More

EC Healthcare Provides Healthcare Services for Signature and Prestige Banking Customers of Hang Seng Bank

indie
3 minutes

HONG KONG, Jul 18, 2022 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce the Group will provide diversified healthcare services for Signature and Prestige Banking customers of Hang Seng Bank via the brands under the Group, including New York Medical Group, Hair Forest, DR REBORN and ATO HAIR CLUB. As the leading healthcare services provider, EC Healthcare is committed to providing professional, premium and diversified medical healthcare services covering 29 medical disciplines and to bringing health, beauty and happiness to the world. EC Healthcare will safeguard the health of banking customers in line with the client-centric core value, and provide comprehensive healthcare, aesthetic and beauty and kids well-being and healthcare services for them and their children. The promotion period started from 1 July 2022 and will end till 30 June 2023.*Please refer to the [Terms and Conditions] on the Hang Seng website for detailed information.About EC Healthcare EC Healthcare is Hong Kong's largest non-hos...

ACN Newswire
Read More

EC Healthcare Received “Institutional Investor” 2022 Multiple Awards in All-Asia Executive Team Rankings

indie
3 minutes

HONG KONG, Jun 27, 2022 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce the excellent result in the "All-Asia Executive Team Rankings 2022" under the category of Healthcare & Pharmaceutical organized by Institutional Investor, an international magazine. The Group is delighted recognize as The Most Honoured Company (Healthcare & Pharmaceutical) in the division - Asia (excluding mainland China), which represents recognition of the Group's impressive performance by the investors and the market. Recognized as an authoritative ranking by industries, "All-Asia Executive Team Rankings" celebrates the outstanding companies and management teams in Asia. Buy-side and sell-side analysts rated the listed companies within the scope of their research according to several criteria used in evaluating performance in corporate governance.Category / AwardCore Asia Results / Best IR TeamAsia ex-Mainland China:The Most Honoured CompanyBest CEO - Mr. Eddy TangBest CFO - Mr. Levin LeeBest Investor Relations Prog...

ACN Newswire
Read More

EC Healthcare Signs Inaugural Dual-Tranche Sustainability-Linked Facility, The First-of-its-Kind in Hong Kong Healthcare Industry

indie
4 minutes

HONG KONG, Jun 21, 2022 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce the signing of its first sustainability-linked facility ("SLL Facility") totalling HK$ 700 million with The Hongkong and Shanghai Banking Corporation Limited ("HSBC") as sole lender and sustainability structuring bank. The inaugural dual-tranche SLL Facility is a first-of-its-kind for a healthcare services provider in Hong Kong, complementing the Group's established status as a leading industry pioneer and reaffirms the importance of sustainability in the Group's future growth strategy. The SLL Facility is comprised of a revolving credit and a term loan, and the proceeds will be used for working capital.The Group is committed to the United Nations 2030 Sustainable Development Goals and has developed a number of clear targets against each of the environmental, social, and governance ("ESG") elements. These include reducing energy consumption, increasing employee engagement, and achieving a globally recognized standard in relati...

ACN Newswire
Read More

Ban Loong, Jacobson & JBM Form Joint Venture to Tap Specialty Drugs and Branded Healthcare Markets in Greater China and Asia

indie
5 minutes

HONG KONG, Jun 15, 2022 - (ACN Newswire via SEAPRWire.com) - Ban Loong Holdings Limited ("Ban Loong", together with its subsidiaries, "Ban Loong Group"; stock code: 0030.HK), of which Yunnan Baiyao Group Co., Ltd. (stock code: 000538.SHE) is the controlling shareholder, Jacobson Pharma Corporation Limited ("Jacobson", together with its subsidiaries (excluding JBM Group), "Jacobson Group"; stock code: 2633.HK) and JBM (Healthcare) Limited ("JBM", together with its subsidiaries, "JBM Group"; stock code: 2161.HK) jointly announced today on forming Ban Loong Jacobson JBM Pharma Limited (the "Joint Venture") to capture the growth opportunities of the specialty pharmaceuticals and branded healthcare markets in Greater China and the Asia-Pacific region.Back row: From left to right: Mr. Tang Ming, Chief Executive Officer of Ban Loong and Mr. Yim Chun Leung, Executive Director of Jacobson & Non-executive Director of JBM witness the signing ceremony; Front row: From left to right: Mr. Liu Zhouyang, Executive Director & Deputy Chief Executive Officer of Ban Loong and Mr. Yu Chun Kau, Chief Financial Officer of Jacobson sign the Joint Venture AgreementThe Joint Venture, which is owned ...

SeaPRwire
Read More

Lemon Healthcare Uses Blockchain Technology to Improve the Smart Healthcare Ecosystem for Patients

pandora
2 minutes

Seoul, Korea,June8, 2022- (SEAPRWire) – Lemon Healthcare, a customized service platform, is using blockchain technology to improve the smart healthcare ecosystem for patients. The company is on a mission to create an efficient and convenient platform that allows patients to access medical records, manage appointments, and communicate with medical professionals. Additionally, the brand behind the platform has launched its own cryptocurrency, LEMONCHAIN (LEMC), which was recently first applied to a Blockchain-based Decentralized Distributed Application (DApp) called “Chung Gu-ui-Shin: All Mighty Reimbursement.” By using blockchain technology, Lemon Healthcare is able to simplify access to medical records and appointment management for patients and healthcare workers. “This innovative healthcare service platform will be a game-changer for the way patients and healthcare workers handle record-keeping, appointment setting, communication, billing, and more. With blockchain technology, we are able to reduce information asymmetry between medical institutions and patients, allowing consumers to actively participate in how their data is stored,” said Tony Lim, COO of Lemon Healthcare. “Our a...

ACN Newswire
Read More

The Executive Talk by ShareInvestor: Thonburi Healthcare Group PCL (SET: THG)

indie
7 minutes

BANGKOK, May 2, 2022 - (ACN Newswire via SEAPRWire.com) - Thonburi Healthcare Group PCL (SET: THG) Chief Executive Officer, Dr. Tanatip Suppradit (M.D.) discusses the business performance during the Covid-19 pandemic, and the economic outlook in 2022.1. What opportunities did you see from the Covid-19 crisis? And how has the Thonburi Healthcare Group managed to handle the situation?It was a crisis, but the crisis is a lesson, as many of you have seen that THG worked very hard. Last year felt like a 10-year work. Over 6-7 thousand, all the employees worked hard all day and night. And the result was satisfactory. Just vaccination alone is hundreds of thousands of people. Not to mention the medical treatment and field hospital where we provided 4-5 thousand beds during the Delta wave. During the Omicron, we are still active today. After the Songkran festival, the case might double. But we must do it because this is our duty. Our occupation is medical treatment and making Thai people safe and disease-free.2. What was the key to success that makes the turnover of THG business performance in 2021?For the key to success, we are a group of hospitals that help the government and civil socie...

ACN Newswire
Read More

G3 Global Gets Shareholders’ Nod for Healthcare Venture and Three Other Resolutions

indie
3 minutes

KUALA LUMPUR, Apr 8, 2022 - (ACN Newswire via SEAPRWire.com) - Artificial Intelligence specialist G3 Global Berhad (G3) has cemented its entry into the higher-margin Healthcare business - beginning with the sale of COVID-19 test kits - after it received approval from its shareholders today. Via a virtual Extraordinary General Meeting (EGM), the shareholders also approved a cash call to grow the Healthcare and ICT divisions; a higher limit to issue new shares; and the engagement in related party transactions (RPT).Dirk Quinten, Managing DirectorFour resolutions were tabled at the EGM, all of which received approval by the voting shareholders. The first resolution was on the proposed diversification into healthcare-related business, whereas the second resolution was on a proposed private placement of up to 432,849,300 new ordinary shares or 20% of G3's total issued shares. The new shares will be issued to independent third-party investors to be identified at a later stage, and the funds raised will be used to expand G3's Healthcare and ICT businesses.In addition, the third resolution was to increase the limit for authority to allot and issue shares from 10% to 20%, while the fourth r...

ACN Newswire
Read More

EC Healthcare Acquires Veterinary Business, Further Consolidate the Pet Service Industry and Increase Market Shares

indie
4 minutes

HONG KONG, Apr 7, 2022 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group acquires 75% equity interests in a company operating veterinary hospital in Tai Po (the "Target Companies") from a registered veterinary surgeon in Hong Kong (The "Seller") for a total consideration of HK$15.75 million in cash. Upon completion of the Acquisition, the financial results of the Target Company will be consolidated into the consolidated financial statements of the Group.The Target Company principally provides veterinary services in Tai Po with four registered veterinary surgeons. According to the unaudited financial information for the seven months ended 31 October 2021, the profit after taxation of the Target Company was approximately HK$2.6 million. The Target Company guarantees to the Group that the aggregate audited net profit after taxation for the three years after the completion of the acquisition should be no less than HK$10,500,000.The Group has been engaging in the veterinary business since ...

ACN Newswire
Read More

Kingworld Medicines Sees 2021 Profit Soar 159% to RMB30.3 Million

indie
6 minutes

HONG KONG, Mar 30, 2022 - (ACN Newswire via SEAPRWire.com) - Kingworld Medicines Group Limited (stock code: 01110.HK), a leading omni-channel enterprise providing world-famous greater health products, announced today its audited consolidated results for the year ended 31 December 2021. Although the Group faced many uncertainties in 2021, it managed to achieve a significant recovery and growth. Revenue increased by 13.7% to approximately RMB847.4 million. Profit attributable to owners of the Company increased by 159% to approximately RMB30.3 million. Basic earnings per share increased by 162% to approximately RMB5 cents. The Board recommends the payment of a final dividend of HK2.39 cents per share for the year ended 31 December 2021 (2020: HK0.65 cents).Pharmaceutical product distribution has been one of the Group's key businesses for many years. In 2021, the sales revenue of Nin Jiom Pei Pa Koa, Nim Jiom Pei Pa Candies and Kingworld Imada Red Flower Oil achieved a year-on-year increase of 85%, 14% and 29%, respectively.In respect of pharmaceutical product distribution business, the Group continued to optimize its channel network layout and made structural adjustments. Based on Mar...

ACN Newswire
Read More

EC Healthcare Launch Tele-Medicine and Drug Delivery Service, Reduce Infection Risk and Protect Citizen’s Health

indie
3 minutes

HONG KONG, Mar 9, 2022 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce, to reduce the infection risk from going out for medical consultation, the Group launch Tele-Medicine service under EC Healthcare Medical Centre, AI MEDICAL, PRIMEcare, chiropractor and traditional medicine services under NYMG. The Group's professional medical team will fully be devoted to providing services to the public. The Group formed a dedicated team that can provide 500 session telemedicine services per day at the first phase and will continue to scale up to match the demand from our clients.Please book via EC Healthcare online platform: https://ectelemedicine.echealthcare.com/If you have any enquiry, please contact Customer Service Hotline: 2152 8503The Tele-Medicine mainly provides common diseases consultation and chronic disease follow-up consultation. The teleconsultation can cover flu, diarrhea, rash, sinusitis, red eye, indigestion, diabetes, hypertension and hyperlipidemia. After the teleconsultation, the Group wi...

ACN Newswire
Read More

G3 Global records highest revenue in Year 2021 on higher COVID-19 test kit distribution solutions

indie
4 minutes

KUALA LUMPUR, Feb 28, 2022 - (ACN Newswire via SEAPRWire.com) - Artificial Intelligence specialist G3 Global Berhad ("G3 Global" or "Group") completed its financial year ended 31 December 2021 ("FY2021") on a positive note as the Group's quarterly revenue surged to the highest level in over 4 years. The stellar performance of its new Healthcare division, where revenue increased by more than 700% quarter-on-quarter ("q-o-q") due to stronger sales of COVID-19 antigen kits, propelled G3 Global closer to its turnaround target.Dirk Quinten, Managing DirectorG3 Global, which also supplies Internet-of-Things (IoT) connected objects and deliver cloud-based data solutions, recorded a revenue of RM18.79 million in the fourth quarter of FY2021, representing a strong growth of more than eight-fold year-on-year ("y-o-y"). The Group had posted a revenue of RM2.29 million in the previous year corresponding quarter.In terms of bottom-line performance, G3 Global registered a loss before tax of RM7.27 million in the fourth quarter of FY2021 as compared to a loss before tax of RM6.97 million a year earlier. The higher amount was due to the ongoing kitchen-sinking exercise undertaken by G3 Global for ...

ACN Newswire
Read More

EC Healthcare Opens New Healthcare Medical Centre, Further Consolidate the Leading Position and Expand Market Share

indie
2 minutes

HONG KONG, Feb 14, 2022 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that, to fulfill the strong demand for medical and healthcare services, the Group is opening a new healthcare medical centre and advanced imaging centre at Cityplaza in Tai Koo,Hong Kong Island, with two newly leased floors with an aggregate gross floor area of approximately 12,300 square feets.The newly leased floors on 14/F of Cityplaza is the EC Healthcare Medical Centre which offers services including but not limited to general medical, specialist, dental and pain management services with a gross floor area of approximately 8,900 square feets and the centre is in full operation from 11 February 2022. The other newly leased floor on 6/F of Cityplaza is an advanced imaging centre serving as a one-stop medical imaging service hub with gross floor area of approximately 3,400 square feets, which is expected to commence operation in March 2022. Together with this new imaging centre, the Group shall have four advanced imaging cen...

ACN Newswire

HMI Group Strengthens Specialist Offering, Acquires Majority Stake in Eagle Eye Centre

indie
6 minutes

- The acquisition bolsters HMI Group's offering of complete one-stop healthcare services and capabilities to patients in Singapore and the region- The partnership strengthens HMI Group and EEC's market position in Southeast Asia, and positions HMI Group for continued growth, synergies, and expansionSingapore, Jan 24, 2022 - (ACN Newswire via SEAPRWire.com) - Health Management International Pte Ltd (HMI Group), a growing regional private healthcare provider with presence in Singapore, Malaysia and Indonesia, has acquired a majority stake in Eagle Eye Centre Pte Ltd (EEC), the largest private ophthalmology chain in Singapore."With our investment, we will partner with EEC and work closely with the EEC doctors to grow the business locally and in the region," said Ms Chin Wei Jia, Group Chief Executive Officer of HMI Group. "This is a significant step in expanding HMI Group's portfolio into the specialist medical services as we strive to provide one-stop healthcare services both within and outside of hospitals."Founded in 2006, EEC started out as a one-stop specialist eye care facility, and was amongst the first to offer comprehensive ophthalmic care with services in all eye subspecialt...

ACN Newswire
Read More

Senior Management Increases Shareholdings in EC Healthcare With Strong Confidence in the Group’s Future Development

indie
3 minutes

HONG KONG, Jan 17, 2022 - (ACN Newswire via SEAPRWire.com) - EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that on 14 January 2022, the Group's Chairman, Executive Director and Chief Executive Officer Mr. Tang Chi Fai ("Mr. Tang") acquired a total of 543,000 shares of the Company on the market for an aggregate consideration of approximately HK$ 4.993 million at an average price of HK$9.1943 per share. As a result, Mr. Tang holds approximately 61.17% of the issued share capital of the Company. On 13 January 2022, Group's Executive Director and Chief Digital Officer Mr. Wong Chi Cheung acquired 40,000 shares of the Company on the open market at an average price of HK$9.725 per share at a total consideration of approximately HK$389,000.Mr. Eddy Tang, Chairman, Executive Director and Chief Executive Officer of EC Healthcare said, "Benefiting from the rising health consciousness and the Group's consistent investment focusing on the healthcare industry, the Group achieved a record high sales volume of no less than HK$880 million in the t...

SeaPRwire

One of Singapore’s trailblazing clinician scientist to break new ground in China

aseanpr
4 minutes

SINGAPORE - One of Singapore's trailblazing clinician scientists, Professor Wong Tien Yin, who is medical director of the Singapore National Eye Centre (SNEC), is forging a new path in Beijing, China, early next year. Taking the road less travelled, as he is wont to do, he will become the founding head of Tsinghua Medicine, a new healthcare and medical sciences academy at Tsinghua University. Prof Wong, 53, who is also SingHealth's deputy group chief executive for research and education as well as vice-dean of the office of academic and clinical development at Duke-NUS Medical School, hopes to inject a bit of Singapore know-how into China to help Tsinghua develop its own academic healthcare system. "We have built a road map and model for academic medicine at the SingHealth Duke-NUS Academic Medical Centre (AMC), and it is time to share some of the lessons and see if ours can be a model for a much larger population in a new culture and environment," he said. This involves developing clinician scientists, preparing medical students for future healthcare problems like ageing and for new healthcare technologies, and more. The perception in Singapore of a clinician scientist has changed...

ACN Newswire
Read More

SinoMab Was Invited to Attend the Inaugural Asia Summit on Global Health

indie
4 minutes

HONG KONG, Nov 26, 2021 - (ACN Newswire via SEAPRWire.com) - SinoMab BioScience Limited ("SinoMab", or the "Company", stock code: 3681.HK), a Hong Kong-based biopharmaceutical company dedicated to the research, development, manufacturing and commercialization of therapeutics for the treatment of immunological diseases, was invited to attend the inaugural Asia Summit On Global Health ("ASGH"), jointly organized by the Government of the Hong Kong Special Administrative Region and the Hong Kong Trade Development Council (HKTDC) yesterday, Dr. Shui On LEUNG, Executive Director, Chairman and Chief Executive Officer of SinoMab, joined the panel discussion on the topic of "What's Next for Healthcare Innovation and Investment".The panel discussion of "What's Next for Healthcare Innovation and Investment"; Dr. Shui On LEUNG, Executive Director, Chairman and Chief Executive Officer of the Company (second right)Dr. Shui On LEUNG was the guest speakerWith the theme of "Shaping a Resilient and Sustainable Future", the Inaugural ASGH was held at the Convention Hall of Hong Kong Convention and Exhibition Centre and synchronized online. At the panel discussion with the topic of "What's Next for He...

ACN Newswire
Read More

Inaugural Asia Summit on Global Health successfully explores healthcare landscape

indie
8 minutes

HONG KONG, Nov 25, 2021 - (ACN Newswire via SEAPRWire.com) - Co-organised by the Government of the Hong Kong Special Administrative Region (HKSAR) and the Hong Kong Trade Development Council (HKTDC), the inaugural Asia Summit on Global Health (ASGH) concluded successfully yesterday (24 November). The summit took place at the Hong Kong Convention and Exhibition Centre (HKCEC) in a hybrid format, offering both online and in-person participation from different regions and time zones, and featured more than 70 speakers, including senior government health officials from around the world, representatives of international organisations, medical research experts, as well as investors and business leaders.More than 21,000 onsite and online participants from 46 countries and regions attended the inaugural Asia Summit on Global Health, co-organised by the Government of the Hong Kong Special Administrative Region and HKTDC.At the Policy Dialogue session, Dr Margaret Chan, Founding Dean, Tsinghua Univ Vanke School of Public Health & Emeritus Director-General, WHO, said "Our best hope to end this pandemic and to bring back normalcy to our life is to ramp up vaccine coverage."The InnoHealth S...